公司
公司
第 11411 位，共 88617 个前 13%本周下降 2453 位
3 条直接关系
所在群组共 219 个紧密关联的对象，核心是
按有证据的公开关系计算，每天更新。
箭头表示关系方向，可按业务类别筛选。
through an exclusive licensing agreement with Elegen Corp.查看来源
Elegen uses proprietary cell-free technologies to build longer, higher-quality DNA on a faster timeline for agricultural, chemical, healthcare, and pharma industries.查看来源
Elegen uses proprietary cell-free technologies to build longer, higher-quality DNA on a faster timeline for agricultural, chemical, healthcare, and pharma industries.查看来源
显示第 1 至 3 条，共 3 条
结合来源阅读结论，展开条目查看证据。
Elegen uses proprietary cell-free technologies to build longer, higher-quality DNA on a faster timeline for agricultural, chemical, healthcare, and pharma industries.
PR Newswire news releases · 2026-10-30 20:00
Elegen uses proprietary cell-free technologies to build longer, higher-quality DNA on a faster timeline for agricultural, chemical, healthcare, and pharma industries.查看来源
Elegen uses proprietary cell-free technologies to build longer, higher-quality DNA on a faster timeline for agricultural, chemical, healthcare, and pharma industries.
PR Newswire news releases · 2026-10-30 20:00
Elegen uses proprietary cell-free technologies to build longer, higher-quality DNA on a faster timeline for agricultural, chemical, healthcare, and pharma industries.查看来源
through an exclusive licensing agreement with Elegen Corp.
PR Newswire news releases · 2026-10-30 20:00
through an exclusive licensing agreement with Elegen Corp.查看来源
显示第 1 至 3 条，共 3 条
估值数据需要 Pro 或 Research。
升级到 Pro 解锁这家公司有哪些页面值得盯着，比如价格、更新日志、条款或招聘页？推荐给我们。每条推荐都有人看；收录后，这个页面会为所有读者一起监测，并且只有连续两次抓取一致才算一次变化。
暂无: 公司信号 · 财务数据 · 披露文件 · 据点 · 业绩指引